Showing results (371-380 of 486) with videos related to

Sort By:
Pageof 49
Cell Cycle (Georgetown, Tex.)|May 18, 2012
Preferential killing of p53-deficient cancer cells by reversineMohamed Jemaà, Lorenzo Galluzzi, Oliver Kepp, et al.
Plos One|December 27, 2007
Inhibition of Chk1 kills tetraploid tumor cells through a p53-dependent pathwayIlio Vitale, Lorenzo Galluzzi, Sonia Vivet, et al.
Frontiers in Immunology|March 28, 2024
LTX-315 triggers anticancer immunity by inducing MyD88-dependent maturation of dendritic cellsXiao-Qing Li, Takahiro Yamazaki, Tianzhen He, et al.
Oncoimmunology|December 18, 2012
Trial watch: Prognostic and predictive value of the immune infiltrate in cancerLaura Senovilla, Erika Vacchelli, Jerome Galon, et al.
Blood|October 11, 2007
Erlotinib exhibits antineoplastic off-target effects in AML and MDS: a preclinical studySimone Boehrer, Lionel Adès, Thorsten Braun, et al.
Oncoimmunology|April 9, 2016
Trial Watch-Immunostimulation with cytokines in cancer therapyErika Vacchelli, Fernando Aranda, Norma Bloy, et al.
Trends in Cancer|February 19, 2022
Immunological control of ovarian carcinoma by chemotherapy and targeted anticancer agentsJitka Fucikova, Lenka Palova-Jelinkova, Vanessa Klapp, et al.
Cytokine & Growth Factor Reviews|June 22, 2013
Crosstalk between ER stress and immunogenic cell deathOliver Kepp, Laurie Menger, Erika Vacchelli, et al.
Oncoimmunology|July 30, 2016
Trial Watch-Small molecules targeting the immunological tumor microenvironment for cancer therapyAitziber Buqué, Norma Bloy, Fernando Aranda, et al.
Oncoimmunology|November 18, 2017
Trial watch: Immune checkpoint blockers for cancer therapyClaire Vanpouille-Box, Claire Lhuillier, Lucillia Bezu, et al.
Pageof 49